Evaluation of SgK269 Expression in Colon Cancer Patients and the Effects of hAMSCs Secretome on Tumor Invasion Through SgK269/C-src/P-P130Cas/P-paxillin/P-ERK1/2 Signaling Pathway in HT-29 Colon Cancer Cells

Researchers evaluated the expression of SgK269 in colon cancer patients and explored the therapeutic effects of human amniotic mesenchymal stromal cells (hAMSCs) on the invasion and proliferation of colon cancer cells (HT-29) by analyzing SgK269/c-Src/p-P130Cas/p-Paxillin/p-ERK1/2 signaling pathway.